3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Plasma cell
1
NET
1
Endocrine
1
Breast
1
Conditions
Multiple Myeloma
9
Peripheral Nervous System Diseases
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Hodgkin Disease
2
Breast Neoplasms
2
Testicular Neoplasms
1
Teratoma, Testicular
1
Teratoma
1
Sezary Syndrome
1
Seminoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pain
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Interventions
trametinib
1
dabrafenib
1
Surveys and Questionnaires
1
Referral and Consultation
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Acupuncture Therapy
×
Plasma cell
×
Clear all
NCT02275403
2019-01-31
ACUFOCIN
The Christie NHS Foundation Trust
Phase 2
Completed
120 enrolled